Top Funding Rounds: Biotech and AI Lead with Big Wins
Biotech and AI sectors see major funding, with Candid Therapeutics' $370M and Glean's $260M rounds leading the way this week.
- Latest
- Trending
Biotech and AI sectors see major funding, with Candid Therapeutics' $370M and Glean's $260M rounds leading the way this week.
Cloudbeds hires AI pioneers to revolutionize hotel tech, enhancing insights and automation for hoteliers worldwide.
Sempra missed Q2 profit and revenue estimates due to California segment's decline, while Texas unit shows potential growth.
Explore the crucial need for financial literacy among college athletes benefiting from NIL deals and the role of educational institutions ...
Qualcomm settles for $75M with shareholders over hidden sales practices; awaits judge's approval. Significant impact on investor trust and market ...
Serve, a startup focused on sidewalk robots, saw its revenue increase to $207,545 last year. The company expects ads to ...
Ventyx Biosciences, Inc. (VTYX) is a high-risk investment with negative net income and high debt ratio, but analysts recommend buying ...
Despite challenges and slow growth, AT&T appeals to income-focused investors due to its substantial dividend yield and sustainable dividend payments. ...
Kratos Defense secures a monumental $579 million contract for military satellite operations, bolstering its market position and commitment to US ...
Sharp HealthCare is leading the way in bringing Apple's Vision Pro VR headset into healthcare. The high-resolution screens and advanced ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.